Skip to main content
Toggle navigation
Login
Search
Home
Tweets by SSO 2022 International Conference on Surgical Cancer Care Featuring Advanced Cancer Therapies
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Presenter
Browse by Presenter
Browse by Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
U
Ullman, Nicholas
University of Rochester Medical Center
A42: A Phase I Study to Evaluate the Safety and Tolerability of SX-682 in Combination with anti-pd1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma
Nicholas Ullman
A42: Q&A
Nicholas Ullman
Back to Top